Scientific deep-dive

Nutrition Drinks Alongside a GLP-1

A real-world study associated nutrition drinks with more fat loss and a better fat-to-lean ratio. The strongest effects were among people who complied, which is a compliance finding wearing a product's clothes.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed
5 min read·1 citation

Oral nutritional supplements, the protein-and-micronutrient drinks sold in every pharmacy, are increasingly marketed to people on GLP-1 drugs. A real-world study found their users lost more weight and more fat, with a better fat-to-lean ratio.[1] The strongest effects appeared among compliers, and that word is doing more work than the product is.

What was observed

Associations with oral nutritional supplement use during GLP-1 therapy. Observational.
MeasureDifference associated with ONS use
BMI−1.4 kg/m²
Body fat−8.4 lb
Total weight−10.1 lb
Body fat ratio−2 percentage points
Lean body mass−5.5 lb (also lost)
Fat-to-lean loss ratio2.3 (favorable)

Effects were strongest among people under 50, those who complied with the supplement, those treated for 181 to 365 days, and those without diabetes.[1]

Why the compliance subgroup is the tell

“The effect was strongest among people who actually took the supplement” sounds like a demonstration that the supplement works. It is at least as consistent with something duller: people who reliably take a supplement are people who reliably do things.

Compliance is a personality trait before it is a product outcome.

Someone who is prescribed nutritional drinks, remembers them daily, and keeps it up for months is also more likely to attend appointments, fill prescriptions on time, escalate their dose on schedule, and exercise. Every one of those independently predicts better results. Dose escalation in particular, which we found most people never complete, is a large determinant of outcome on its own.

This is an observational comparison from a single clinic’s records: of 252 patients, 88 who were prescribed the drinks were matched with 32 who were not.[1] The drinks were prescribed only to people diagnosed with protein malnutrition, so the two groups differed before treatment began. The authors note that matching may not fully balance nutritional status between them, and no statistical adjustment fully removes a difference like that.

Apply the same scrutiny you would to a drug claim. A supplement finding tends to get an easier ride than a pharmaceutical one, and it should not. This study was funded by Abbott, which makes nutrition drinks, and three of its eight authors are Abbott employees and stockholders; the paper states that the funder had no role in the analysis.[1] The commercial incentive to publish a positive result exists in both industries, and the study designs available to supplements are usually weaker.

What is plausibly real underneath it

There may well be something here, and it is not exotic. These drinks deliver protein and micronutrients in a form that requires no appetite, no cooking and no chewing, which is a real advantage when a drug has removed the desire to eat.

The targets themselves are established: at least 1.2 g of protein per kilogram daily, and a panel of micronutrients worth monitoring, both covered in protein targets and the lab panel. A drink that helps someone reach those is doing something useful. So is chicken.

  • The mechanism on offer is protein and micronutrients, not a property of the format.
  • Food does the same job and costs less, for anyone who can manage it.
  • The case for a drink is practical: low appetite, nausea, or no time, which are the conditions where liquid beats a plate.
  • The intervention with randomized support is resistance training, covered in lean mass, drug versus dieting. No supplement has that behind it.

Frequently Asked Questions

A real-world study associated their use with more weight and fat loss and a better fat-to-lean ratio. It compared patients prescribed the drinks for diagnosed protein malnutrition against patients who were not, at a single clinic. That is not a random difference, so the association is weaker evidence than it looks.
Because people who reliably take a supplement are people who reliably do things: attend appointments, fill prescriptions, escalate their dose on schedule. All of those independently predict better outcomes, and dose escalation especially.
Probably. These drinks deliver protein and micronutrients without requiring appetite, cooking or chewing, which is a real advantage when a drug has removed the desire to eat. The mechanism is the nutrition, not the format.
Yes, and it costs less. The case for a drink is practical rather than nutritional: low appetite, nausea or no time. If you can meet the protein and micronutrient targets from food, there is no established advantage to buying a supplement.
Resistance training, which is the only intervention with randomized evidence behind it for changing the proportion of weight lost as lean mass. No nutritional supplement has that support.

References

  1. 1.Hong K, Sulo S, Wang W, et al. Oral Nutritional Supplements and Body Composition Outcomes Among GLP-1 Receptor Agonist Users: Real-World Evidence Diabetes, Metabolic Syndrome and Obesity. 2026. PMID: 42117035.

Plant-Based Protein on a GLP-1: What Closes the Gap, and Why the Drug Widens It

Across a full day at high protein intake a vegan diet matched an omnivorous one for muscle. Per meal, an omnivorous meal produced about 47% more muscle protein synthesis than a vegan one, and a GLP-1 works against the intake that closes the gap.

7 min read

Protein Targets and the Lab Panel

At least 1.2 g of protein per kg daily, 0.3–0.4 g/kg per meal, and a short lab panel: vitamin D, B12, iron studies, folate and zinc, plus thiamin in high-risk patients. The upper protein target excludes chronic kidney disease.

5 min read

Creatine on a GLP-1: The Trial Nobody Has Run

No completed trial has tested creatine in people taking a GLP‑1. The 2026 review of lean-mass preservation classes it as indirect evidence, and the lean-mass number most often quoted for it is one creatine inflates.

6 min read

The Diet Advice Nobody Has Tested

Everyone on these drugs is told to hit a protein target, drink more, add fiber. A review of 16 randomized trials of these drugs given alongside dietary guidance concluded that evidence on the optimal nutritional approach remains limited.

7 min read

Capsaicin and Capsinoids for Weight Loss: Eight Measures, Eight Nulls

A dose-response meta-analysis of 13 randomized trials and 838 participants found no effect of capsinoids on body weight, BMI, waist circumference, fat mass, fat-free mass, waist-hip ratio, visceral fat or body fat percentage.

5 min read

GLP-1s During Ramadan: What the Four Studies Actually Tested

Four studies exist on taking a GLP‑1 through Ramadan and all four enrolled people with type 2 diabetes. Both randomized trials compared against a sulfonylurea, a drug class whose defining hazard is low blood sugar.

7 min read

Where to get GLP-1 online, safely: sellers our editors have checked

These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

9.1

Collective

Flat any-dose pricing, if you can absorb a $199 annual membership on top

From $59/mo + membership

Get started →
Read full review →
9.3

Embody

A flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies

6.4

Bodybuilding Health+

Seeing what it charges before you answer any medical questions

About this analysis

GLP Watchdog publishes independently. Each seller in our dataset is checked against that seller's own website, and the dataset is updated continuously. Read our full methodology →